Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Arnold, M. Wormald, Robert Sim, P. Rudd, R. Dwek (2007)
The impact of glycosylation on the biological function and structure of human immunoglobulins.Annual review of immunology, 25
Andreia Peixoto, Marta Relvas-Santos, R. Azevedo, L. Santos, J. Ferreira (2019)
Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer HallmarksFrontiers in Oncology, 9
S Schedin-Weiss (2014)
46FEBS J, 281
Henriette Haukedal, K. Freude (2021)
Implications of Glycosylation in Alzheimer’s DiseaseFrontiers in Neuroscience, 14
B. Cobb (2019)
The History of IgG Glycosylation and Where We Are Now.Glycobiology
A. Mehta, Harmin Herrera, T. Block (2015)
Glycosylation and liver cancer.Advances in cancer research, 126
N. Rudman, O. Gornik, G. Lauc (2019)
Altered N‐glycosylation profiles as potential biomarkers and drug targets in diabetesFEBS Letters, 593
Y. Miura, T. Endo (2016)
Glycomics and glycoproteomics focused on aging and age-related diseases--Glycans as a potential biomarker for physiological alterations.Biochimica et biophysica acta, 1860 8
J. Shang, G. Ye, K. Shi, Yushun Wan, C. Luo, H. Aihara, Q. Geng, Ashley Auerbach, Fang Li (2020)
Structural basis of receptor recognition by SARS-CoV-2Nature, 581
Romain Péanne, P. Lonlay, F. Foulquier, U. Kornak, D. Lefeber, E. Morava, B. Perez, N. Seta, C. Thiel, E. Schaftingen, G. Matthijs, J. Jaeken (2017)
Congenital disorders of glycosylation (CDG): Quo vadis?European journal of medical genetics, 61 11
Sheng Pan, T. Brentnall, Ru Chen (2016)
Glycoproteins and glycoproteomics in pancreatic cancerWorld Journal of Gastroenterology, 22
A. Imberty, A. Varrot (2008)
Microbial recognition of human cell surface glycoconjugates.Current opinion in structural biology, 18 5
Maja Christiansen, Jenny Chik, L. Lee, Merrina Anugraham, Jodie Abrahams, N. Packer (2014)
Cell surface protein glycosylation in cancerPROTEOMICS, 14
J. Vliegenthart (2006)
Carbohydrate based vaccinesFEBS Letters, 580
A. Shajahan, N. Supekar, A. Gleinich, P. Azadi (2020)
Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2Glycobiology, 30
A. Walls, Young-Jun Park, M. Tortorici, A. Wall, Andrew McGuire, D. Veesler (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike GlycoproteinCell, 181
Jared Gerlach, M. Griffin (2016)
Getting to know the extracellular vesicle glycome.Molecular bioSystems, 12 4
Naveen Vankadari, J. Wilce (2020)
Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26Emerging Microbes & Infections, 9
S. Albrecht, L. Unwin, M. Muniyappa, P. Rudd (2014)
Glycosylation as a marker for inflammatory arthritis.Cancer biomarkers : section A of Disease markers, 14 1
H. Schachter, H. Freeze (2009)
Glycosylation diseases: quo vadis?Biochimica et biophysica acta, 1792 9
R. Aquino, P. Park (2016)
Glycosaminoglycans and infection.Frontiers in bioscience, 21
Sophia Schedin‐Weiss, B. Winblad, L. Tjernberg (2014)
The role of protein glycosylation in Alzheimer diseaseThe FEBS Journal, 281
A. Planinc, J. Bones, B. Dejaegher, P. Antwerpen, C. Delporte (2016)
Glycan characterization of biopharmaceuticals: Updates and perspectives.Analytica chimica acta, 921
R. Schnaar (2016)
Glycobiology simplified: diverse roles of glycan recognition in inflammationJournal of Leukocyte Biology, 99
K. Mariño, R. Saldova, B. Adamczyk, P. Rudd (2011)
Chapter 3:Changes in Serum N-Glycosylation Profiles: Functional Significance and Potential for Diagnostics
L. Ruhaak, H. Uh, A. Deelder, R. Dolhain, M. Wuhrer (2014)
Total plasma N-glycome changes during pregnancy.Journal of proteome research, 13 3
I. Gudelj, G. Lauc, Marija Pezer (2018)
Immunoglobulin G glycosylation in aging and diseases.Cellular immunology, 333
A. Magalhães, H. Duarte, C. Reis (2017)
Aberrant Glycosylation in Cancer: A Novel Molecular Mechanism Controlling Metastasis.Cancer cell, 31 6
E. Dempsey, P. Rudd (2012)
Acute phase glycoproteins: bystanders or participants in carcinogenesis?Annals of the New York Academy of Sciences, 1253
S. Groux-Degroote, Sumeyye Cavdarli, K. Uchimura, F. Allain, P. Delannoy (2020)
Glycosylation changes in inflammatory diseases.Advances in protein chemistry and structural biology, 119
R. Bhusal, S. Foster, M. Stone (2020)
Structural basis of chemokine and receptor interactions: Key regulators of leukocyte recruitment in inflammatory responsesProtein Science, 29
Emily Rodrigues, Matthew Macauley (2018)
Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic OpportunitiesCancers, 10
W. Breedam, S. Pöhlmann, H. Favoreel, R. Groot, H. Nauwynck (2014)
Bitter-sweet symphony: glycan–lectin interactions in virus biologyFEMS Microbiology Reviews, 38
V. Venkatakrishnan, M. Thaysen‐Andersen, S. Chen, H. Nevalainen, N. Packer (2015)
Cystic fibrosis and bacterial colonization define the sputum N-glycosylation phenotype.Glycobiology, 25 1
V. Vanhooren, W. Laroy, C. Libert, C. Chen (2008)
N-Glycan profiling in the study of human agingBiogerontology, 9
J. Hütter, B. Lepenies (2015)
Carbohydrate-Based Vaccines: An Overview.Methods in molecular biology, 1331
J. Dennis, I. Nabi, M. Demetriou (2009)
Metabolism, Cell Surface Organization, and DiseaseCell, 139
S. Kim, Weihua Jin, Amika Sood, David Montgomery, Oliver Grant, M. Fuster, Li Fu, J. Dordick, R. Woods, Fuming Zhang, R. Linhardt (2020)
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactionsAntiviral Research, 181
Daisuke Takakura, M. Tada, N. Kawasaki (2016)
Membrane glycoproteomics of fetal lung fibroblasts using LC/MSPROTEOMICS, 16
A. Thompson, R. Vries, J. Paulson (2019)
Virus recognition of glycan receptorsCurrent Opinion in Virology, 34
B. Xia, J. Royall, G. Damera, G. Sachdev, R. Cummings (2005)
Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis.Glycobiology, 15 8
Yasunori Watanabe, Joel Allen, D. Wrapp, J. McLellan, M. Crispin (2020)
Site-specific glycan analysis of the SARS-CoV-2 spikeScience (New York, N.y.), 369
A. Cvetko, D. Kifer, O. Gornik, L. Klarić, E. Visser, G. Lauc, James Wilson, T. Štambuk (2020)
Glycosylation Alterations in Multiple Sclerosis Show Increased Proinflammatory PotentialBiomedicines, 8
[This chapter briefly looks at the involvement of carbohydrates in diseases. Glycosylation of proteins is one of the most common posttranslational modifications in eukaryotic cells. Subsequently, many glycoproteins specifically decorate the cells with their glycans. Pathogenic bacteria and viruses benefit from the exuberant presence of carbohydrates on the cell surface. Their interaction with specific glycan epitopes leads to infections and inflammations. Furthermore, significant alterations of cell glycans occur during many diseases, including cancer and congenital disorders of glycosylation (CDG). Monitoring changes in glycosylation (e.g., in human serum) reveals a specific and sensitive approach to biomarker discovery and disease diagnosis.]
Published: Oct 24, 2021
Keywords: Diabetes; Bacteria; Viruses; Rheumatoid arthritis; COVID-19; HIV; AIDS; Malaria; Inflammatory bowel disease (IBD); Crohn’s disease; Pompe’s disease; Hurler’s disease; Sandhoff disease; Tay-Sachs disease; Cancer
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.